BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17849475)

  • 21. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.
    Hansen LV; Skov BG; Ploug M; Pappot H
    Lung Cancer; 2007 Nov; 58(2):260-6. PubMed ID: 17706320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition.
    Jacobsen B; Ploug M
    Curr Med Chem; 2008; 15(25):2559-73. PubMed ID: 18855679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.
    Oshiro R; Yamamoto H; Takahashi H; Ohtsuka M; Wu X; Nishimura J; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
    Cancer Sci; 2012 Jun; 103(6):1155-64. PubMed ID: 22404718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
    Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
    Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.
    Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T
    Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer.
    Tamoto E; Tada M; Murakawa K; Takada M; Shindo G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Kawakami A; Fujiwara Y; Kobayashi N; Shirata K; Nishimura N; Okushiba S; Kondo S; Hamada J; Yoshiki T; Moriuchi T; Katoh H
    Clin Cancer Res; 2004 Jun; 10(11):3629-38. PubMed ID: 15173069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
    Takala H; Kauppila JH; Soini Y; Selander KS; Vuopala KS; Lehenkari PP; Saarnio J; Karttunen TJ
    J Innate Immun; 2011; 3(6):631-8. PubMed ID: 21876325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus.
    Wickborn C; Klein-Szanto AJ; Schlag PM; Braunewell KH
    Mol Carcinog; 2006 Aug; 45(8):572-81. PubMed ID: 16683251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas.
    Kainulainen T; Autio-Harmainen H; Oikarinen A; Salo S; Tryggvason K; Salo T
    Br J Dermatol; 1997 Mar; 136(3):331-6. PubMed ID: 9115910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma.
    Tateno T; Ueno S; Hiwatashi K; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Sakoda M; Kubo F; Ishigami S; Shinchi H; Natsugoe S
    Ann Surg Oncol; 2009 Feb; 16(2):440-6. PubMed ID: 19023628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
    Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
    Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
    Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
    Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas.
    Liu P; Chen S; Wu W; Liu B; Shen W; Wang F; He X; Zhang S
    Jpn J Clin Oncol; 2012 Jul; 42(7):612-8. PubMed ID: 22581910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
    Goscinski MA; Suo ZH; Nesland JM; Chen WT; Zakrzewska M; Wang J; Zhang S; Flørenes VA; Giercksky KE
    Oncology; 2008; 75(1-2):49-59. PubMed ID: 18787344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
    Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
    Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
    Yamamoto H; Itoh F; Iku S; Hosokawa M; Imai K
    Clin Cancer Res; 2001 Apr; 7(4):896-900. PubMed ID: 11309339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.